| Application | Recommended Dilution |
|---|---|
| ELISA | 1:5000-1:50000 |
DLK1, also known as Protein delta homolog 1, serves as a critical regulator of cell differentiation and plays significant roles in adipogenesis, neurogenesis, and hematopoiesis. This transmembrane protein, which can be proteolytically cleaved to release the soluble Fetal antigen 1 (FA1), has garnered considerable research attention for its involvement in developmental processes and its aberrant expression patterns observed in various pathological conditions, including certain cancers and metabolic disorders.
This recombinant monoclonal antibody against human DLK1, clone 14A2, offers researchers the reproducibility and consistency that only sequence-defined recombinant technology can provide. Unlike traditional hybridoma-derived antibodies that may exhibit batch-to-batch variation, this antibody delivers reliable performance across experiments, ensuring that your results remain comparable over time and between studies.
Validation data demonstrates exceptional binding characteristics in ELISA applications, with an EC50 range of 1.935-2.143 ng/mL when tested against immobilized human DLK1 protein. This high-affinity binding supports sensitive detection at recommended dilutions spanning 1:5000 to 1:50000, providing flexibility to optimize conditions for your specific experimental setup. The human IgG1 isotype format and affinity-chromatography purification ensure high purity suitable for quantitative immunoassays.
Supplied in a glycerol-based buffer system optimized for long-term stability at -20°C or -80°C, this antibody maintains its activity when handled according to recommended storage guidelines. Researchers investigating stem cell biology, developmental pathways, tumor marker expression, or metabolic regulation will find this antibody a valuable tool for detecting and quantifying DLK1 in human samples through ELISA-based approaches.
Email: support@cusabio.com
Distributors Worldwide